Highlights
NASDAQ: SPRO       Spero Therapeutics Inc
Last Price Today's Change   Day's Range   Trading Volume
10.92   -0.09 (0.82%)  10.612 - 11.02  57,405

Overview

 
Avg Volume (4 weeks):50,757
4 Weeks Range:9.35 - 12.465
4 Weeks Price Volatility (%):
50.40%
52 Weeks Range:5.52 - 14.48
52 Weeks Price Volatility (%):
60.27%
Average Price Target:-

Headlines



No recent Headlines for this stock.


Business Background

Spero Therapeutics Inc is a US-based clinical-stage biopharmaceutical company. It focuses on identifying, developing and commercializing novel treatments for MDR (Multi-drug-resistant) bacterial infections. The company's product candidate, SPR994, is designed as a broad-spectrum oral carbapenem-class antibiotic for use in adults to treat MDR Gram-negative infections. It has developed platform technology known as Potentiator Platform to develop drugs to expand the spectrum and potency of existing antibiotics, including formerly inactive antibiotics, against Gram-negative bacteria. In addition, the company is developing SPR720, an oral antibiotic designed for the treatment of pulmonary non-tuberculous mycobacterial infections. The pipeline products include SPR741, SPR206, and SPR720.

  Be the first to like this.
 


 

3640  2100  313  2918 

ActiveGainersLosers
Top 10 Active Counters
 NameLastChange 
 CELG 108.24+0.11 
 GE 11.44+0.47 
 AMD 42.59+3.12 
 DHR 151.30+1.63 
 CHK 0.783+0.037 
 BAC 34.68+1.04 
 FCEL 0.707+0.144 
 AMRX 5.04+1.56 
 AABA 19.630.00 
 F 9.32+0.21 
Partners & Brokers